Total Funding
55
Total FundingSeries D raised
Growth Score in past quarter
pts
Heat Score 55 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
27507
Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.
- Andy Tsun: VP of Discovery Biology & Co-Founder
- Xiaolin Liu: CEO & Founder
About the Company
Biotheus is a biotech company that focuses on curing malignant tumors and autoimmune diseases. Biotheus is committed to the research, development, and commercialization of first-class innovative biologics mainly through the discovery of next-generation multispecific antibodies.

